Phase 3

Bitopertin Phase 3 Meets Dual EPP Endpoints

Disc Medicine reported that the randomized Phase 3 APOLLO trial met both co-primary endpoints and every prespecified secondary endpoint in erythropoietic protoporphyria and X-linked protoporphyria. The result directly addresses the clinical-benefit evidence gap identified…

Saturday Rounds

Agenus Raises Up to $340M on Neoadjuvant MSS Colon Cancer
Infinimmune Raises $75 Million for Two Atopic-Dermatitis Antibodies
GenScript Raises HK$2.33 Billion for AIDD Expansion
TriGemX Raises $94 Million for Phase 3 Migraine Trials